arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences

FT-FMCNA Chronic Care Forum

The Key to Sustainable Healthcare

New York |
Speakers include:
Ron Kuerbitz

Ron Kuerbitz

Fresenius Medical Care North America

Susan DeVore

Susan DeVore

Premier, Inc

Mike Weissel

Mike Weissel

Optum

Overview

According to the CDC*, chronic diseases are responsible for 7 of 10 deaths each year, and treating people with chronic diseases accounts for 86% of our nation’s health care costs. These numbers highlight that new ways to prevent the onset and manage the care of patients with multiple complex chronic conditions will need to be found if the healthcare system is to remain sustainable. Providers and payers alike are developing new integrated care models in which patients become partners in the management of their own care, and in which healthcare professionals work seamlessly across the care continuum to better coordinate care. But while these new models are the vision for the future and continue to be an area of rich experimentation, important questions remain. For example, how successful will current and proposed chronic care initiatives be in bending the cost curve and improving the care of the chronically ill? Does the definition of medical care need to be redefined to take account of the needs of the chronically ill? What is the potential – and limitations – of self-managed care, and what does the future hold for patients taking much more accountability and responsibility for their care?

The FT-FMCNA Chronic Care Forum: The Key to Sustainable Healthcare will bring together key stakeholders in the care and management of the chronically ill - to include providers, payers, physicians and patients - to share frontline perspectives on the challenges and opportunities they face in integrating and improving care, and to discuss how current and emerging chronic care models are transforming the healthcare landscape.

*http://www.cdc.gov/chronicdisease/

fallback
fallback Add to my Calendar 11/04/2015 08:00:0011/04/2015 11:30:00falseFT-FMCNA Chronic Care ForumAccording to the CDC*, chronic diseases are responsible for 7 of 10 deaths each year, and treating people with chronic diseases accounts for 86% of our nation’s health care costs. These numbers highlight that new ways to prevent the onset and manage the care of patients with multiple complex chronic conditions will need to be found if the healthcare system is to remain sustainable. Providers and payers alike are developing new integrated care models in which patients become partners in the management of their own care, and in which healthcare professionals work seamlessly across the care continuum to better coordinate care. But while these new models are the vision for the future and continue to be an area of rich experimentation, important questions remain. For example, how successful will current and proposed chronic care initiatives be in bending the cost curve and improving the care of the chronically ill? Does the definition of medical care need to be redefined to take account of the needs of the chronically ill? What is the potential – and limitations – of self-managed care, and what does the future hold for patients taking much more accountability and responsibility for their care?The FT-FMCNA Chronic Care Forum: The Key to Sustainable Healthcare will bring together key stakeholders in the care and management of the chronically ill - to include providers, payers, physicians and patients - to share frontline perspectives on the challenges and opportunities they face in integrating and improving care, and to discuss how current and emerging chronic care models are transforming the healthcare landscape.*http://www.cdc.gov/chronicdisease/FT-FMCNA-Chronic-Care-Forum56b3cfdd52b38b85d2b6d4fefb8f1191MM/DD/YYYY

FT-FMCNA Chronic Care Forum Brochure

Download Brochure
Download Brochure

FMCNA Health Indicator Report Press Release

Read Complete Press Release

FMCNA Health Indicator Chronic Care Report

View the Report Here

Keynote (1)

Ron Kuerbitz

Ron Kuerbitz

CEO
Fresenius Medical Care North America

Ron Kuerbitz was appointed Chief Executive Officer of Fresenius Medical Care North America (FMCNA) in January 2013 after holding executive positions in operations and administration within the organisation for more than 15 years. Under his leadership, FMCNA has evolved to become the country’s leading provider of integrated health care services for renal patients, and its capabilities have expanded into hospitalist medicine, cardiovascular care and programs designed to flourish in a consumer and value driven health care system.

From 2010-2013 Mr Kuerbitz served as Chairman of Kidney Care Partners, a coalition of industry advocates, where he introduced and garnered support for a bundled payment methodology from Medicare for dialysis services, which has yielded significant improvements in the quality and efficiency of care. A graduate of Yale Law School, Mr Kuerbitz is also a member of the Management Board of Fresenius Medical Care AG & Co. KGaA, the parent company of FMCNA based in Frankfurt, Germany.

Speakers (4)

Susan DeVore

Susan DeVore

President and CEO
Premier, Inc

Susan DeVore is President and CEO of Premier, Inc, one of the nation's leading healthcare improvement companies. Uniting an alliance of approximately 3,600 US community hospitals and 120,000 other providers to transform healthcare, Premier enables better care and outcomes at a lower cost. Ms DeVore is an industry-leading thinker who has been named multiple times to Modern Healthcare's 100 Most Influential and Top 25 Women in Healthcare Lists. DeVore has also been recognized as one of the 100 most influential leaders by the Association to Advance Collegiate Schools of Business (2015), Charlotte Business Woman of the Year (2015), and as the recipient of the 2014 Silver Stevie Award for Executive of the Year. Ms DeVore currently serves as Chairman of the Board Trustees of the Healthcare Leadership Council, Board Member of the Coalition to Protect America’s Healthcare and Board Member, Finance Committee member and Audit Committee Chair of the Medicare Rights Center. She also serves as a member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare and the Charlotte Chamber Executive Committee. Under Ms DeVore's leadership, Premier has built an industry-leading code of ethics, been named eight times as one of the World's Most Ethical Companies by Ethisphere, won the Malcolm Baldrige National Quality Award, been named four times to InformationWeek's 500 top technology innovators in the nation and won IBM's CTO innovation award for advanced analytics in healthcare.

Mike Weissel

Mike Weissel

Executive Vice President
Optum

Mike Weissel joined Optum in 2013 and is an Executive Vice President and CEO of the Consumer Solutions Group. The Consumer Solutions Group (CSG), part of Optum Health, provides solutions to help payers, providers, employers and governments improve the health of their population with a focus on three key areas to include Population Health Management, Financial Services and Distribution Services. Prior to joining Optum, Mr Weiseel was with the international management consulting firm Oliver Wyman for 17 years. He founded Oliver Wyman’s Health & Life Sciences practice in 2007, and served as Managing Partner and Global Leader for that practice until 2013. Prior to Oliver Wyman, Mr Weissel was a Certified Public Accountant and Associate Partner at Price Waterhouse. He holds an MBA from Duke University and a BA from the University of Massachusetts.

Thomas Scully

Thomas Scully

General Partner, Welsh, Carson, Anderson & Stowe
Former Administrator, Centers for Medicare and Medicaid Services (CMS)

Tom Scully is a General Partner with Welsh, Carson, Anderson & Stowe, a private equity firm in New York which is the most active US private equity investor in healthcare. Mr Scully was the Administrator of the Centers for Medicare & Medicaid Services (CMS) from 2001 to 2004. CMS administers Medicare, Medicaid, SCHIP, and is the largest agency in the US Government, spending more than $1 trillion for fiscal year 2015. In this capacity, Mr Scully had an instrumental role in designing and passing Medicare reform and Medicare Part D legislation and in making the vast agency more open and accountable to the public. He initiated the first public reporting and disclosure for comparative quality among hospitals, nursing homes, home health agencies and dialysis centers. Before joining CMS, Mr Scully served as President and CEO of the Federation of American Hospitals (FAH) from 1995 to 2001. The FAH represents 1700 privately owned hospitals. Mr Scully was a Partner in Washington, D.C., with Patton Boggs, LLP, 1993-95; Deputy Assistant to the President and Counselor to the Director OMB, 1992-93; and an Associate Director of OMB, 1989-92. Mr Scully worked on the Bush for President campaign in 1988; practiced law with Akin Gump from 1985-1988; and served with US Senator Slade Gorton (WA), 1980-1985.

John Birkmeyer

John Birkmeyer

Executive Vice President, Integrated Delivery System and Chief Academic Officer
Dartmouth-Hitchcock Health

John Birkmeyer is Executive Vice President of Integrated Delivery System and Chief Academic Officer at Dartmouth-Hitchcock Health, an academic health system with over 1,000 physicians spanning a large regional network of affiliated hospitals and practices. A graduate of Boston College and Harvard Medical School, he joined the Dartmouth faculty in 1996 and was subsequently appointed Chief of General Surgery. In 2004, he moved to University of Michigan as the George D. Zuidema Professor of Surgery and the Director of the Center for Healthcare Outcomes & Policy. He returned to Dartmouth-Hitchcock in 2014. Dr Birkmeyer is also Founder and Chief Scientific Officer of ArborMetrix, Inc., a healthcare analytics and services company in Ann Arbor. An elected member of the National Academy of Medicine (formerly IOM), Dr Birkmeyer is an internationally recognized leader in outcomes research and understanding variation in the outcomes and efficiency of hospitals and physicians. He has published over 250 articles in scientific literature, many of which have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet, and Health Affairs. He has a long track record of funding from the AHRQ and the National Institutes of Health. 

fallback

Chairperson (1)

Andrew Ward

Andrew Ward

Energy Editor
Financial Times

Andrew Ward is the FT’s Energy Editor, leading global coverage of the oil and gas industry, power generation and related policy and geopolitical issues. Before taking up his current role in June 2016, Ward was Pharmaceuticals Correspondent, reporting on life sciences, medical technology and healthcare.

Prior to this, Ward was UK News Editor, leading the news desk responsible for the FT’s coverage of UK politics, policy and economics. Previously, Ward served the FT in a number of foreign reporting roles. He was the Nordic bureau chief responsible for coverage of eight countries – Sweden, Norway, Finland, Iceland, Denmark and the three Baltic states of Latvia, Estonia and Lithuania.

Ward has also been the White House correspondent, during which role he covered the George W. Bush administration and the 2008 presidential election campaign. Before moving to Washington, Ward covered business and politics in the US south-east as Atlanta Correspondent. Between 2001 and 2004, he served as Seoul Correspondent, reporting on North and South Korea.

Ward joined the FT in 1999 as a graduate trainee in London and was appointed Media Correspondent in 2000. Ward received his B.A. in Politics and Modern History from the University of Manchester, UK.

Follow Andrew Ward on twitter: @andrew_ward1

Agenda - 4th Nov

  • 8:00am
    Registration and Breakfast
  • 9:00am
    Chairman's Opening Remarks

    With the treatment of chronic diseases already accounting for 45% of healthcare spend in the US, and rising, new ways to prevent the onset and manage patients with complex chronic conditions will need to be found if the healthcare system is to remain sustainable into the future. Today’s event will explore the extent to which the healthcare system is meeting the needs of chronically ill patients.Does ‘medical care’ need to be redefined to take account of their needs? What are the key innovations in delivery and payment models-the vision for integrated and patient centred care-to support the needs of chronic care providers and patients, and what can we expect going forward? How can the data opportunity be maximised to take chronic care management to the next level? How successful will current and proposed initiatives in bending the cost curve and improving the care of the chronically ill? How will current and emerging chronic care models transform the US Healthcare landscape?

    Andrew Ward, Pharmaceutical Correspondent, Financial Times

  • 9:15am
    Keynote Interview

    Ron Kuerbitz, CEO, Fresenius Medical Care North America in conversation with Andrew Ward

  • 9:45am
    Stakeholder Forum: The Future of Chronic Care-Where Do We Go From Here?

    As healthcare systems begin to move from volume-based to value-based care, a great deal of attention has been placed on the need to improve access to primary care and coordination among specialists. But many of the innovations thus far have focused on the acute or post-acute setting. Improving care for chronically ill patients who account for a large portion of physicians’ time and total healthcare spending remains a challenge. Providers, payors and physicians are trying to develop new and better ways to care and improve outcomes for the chronically ill, but how effective have these approaches been to date and how can they be improved? What are the learnings from the key stakeholders and what are their ideas for the way forward?

    • What have been the key interventions that have resulted in improved care of the chronically ill, and the challenges encountered?
    • What do stakeholders view as the policy initiatives which would best improve care and management of patients?
    • Role and responsibilities: who is best placed to manage/oversee the care of the chronically ill? What is the role of the physician, nurse, physician assistant or alternative medical practitioner, the patient?
    • What needs to happen for patients to become true ‘partners’ in their care-including the potential and limitations of self-managed care? What is the view of the patient on how their needs can best be addressed? How empowered do patients feel to adequately manage their conditions?
    • What has been the reality of integrated care from the physician perspective? To what extent has cooperating with other professionals across the care continuum helped or hindered the process of caring for patients? How useful has access to aggregate data been to decision making? How confident are physicians that their patients can be entrusted to self-manage their conditions? What has been the impact on the patient–physician relationship?
    • Are current models of chronic care movement too medically /clinically focused? How can current models be be evolved to take account of social, environmental and other more holistic parameters of care?
    • How should success be measured?
    • A sense of place; what is the role of the home, alternative healthcare settings include retail health in the management of the chronically ill?

    John Birkmeyer, Executive Vice President, Integrated Delivery System and Chief Academic Officer, Darmouth-Hitchcock Health

    Susan DeVore, President and CEO, Premier, Inc 

    Ron Kuerbitz, CEO, Fresenius Medical Care North America

    Thomas Scully, Partner, Welsh, Carson, Anderson & Stowe, Former Administrator, Centers for Medicare and Medicaid Services (CMS)

    Mike Weissel, Executive Vice President, Optum

  • 10:45am
    Closing Remarks from the Chair
  • 10:50am
    Close of Forum - Networking Coffee Break

Why Attend?

  • Hear the views of industry experts on how healthcare is being redefined to take account of the needs of the chronically ill
  • Gain critical insights into the evolution of value-based care in the US and the challenge and opportunities this presents for chronic care providers, payers and patients
  • Explore new and better ways to care for and improve outcomes for the chronically ill
  • Discuss how the vision of patient-centered, integrated care can be delivered
  • Network with peers across the care continuum-payers, provider, physicians and patient representatives
fallback

Who Attends?

This invitation only event is for ​CEO, CFO, Managing Director, Chief Medical Officer, Chief Clinical Director, Head of Clinical Innovation, Head of Strategy from the following organizations:

  • Payers-government and health insurers
  • Providers-hospitals and clinics
  • Integrated healthcare delivery systems including ACOs/Managed Care/Population Health Management
  • Physician groups and organisations
  • Private equity
  • Investment banks

Additional senior applicants will be considered for invitation subject to availability of places and meeting the above criteria. Apply today as spaces are limited.

fallback

Venue

The Metropolitan Club
One East 60th Street (at Fifth Avenue)
New York 10022

United States of America

Tel: +1 212-838-7400

fallback

Organizers (2)

The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community.

Fresenius Medical Care North America is the premier health care company focused on delivering the highest quality care to people with renal and other chronic conditions. 

Worldwide, more than 2.5 million patients with this disease regularly undergo dialysis therapy, a vital blood cleansing procedure that substitutes the function of the kidney in the case of kidney failure.

Through our industry-leading network of more than 2,200 dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers, as well as the country’s largest practice of hospitalist and post-acute providers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s only vertically integrated renal company, we also offer specialty pharmacy and laboratory services, as well as manufacturing and distributing the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals.

Our integrated approach helps to not only improve patients' health outcomes, but also reduce the total cost of care.

Our North American headquarters is in Waltham, Massachusetts.

Contact Us

Angela Letinov
Speaking Opportunities
Financial Times
Meredith Vachon
Media Partner & Press Inquiries
Financial Times